CU23814A3 - Emulsión intravenosa de butilftalida y aplicación de la misma - Google Patents
Emulsión intravenosa de butilftalida y aplicación de la mismaInfo
- Publication number
- CU23814A3 CU23814A3 CU20080114A CU20080114A CU23814A3 CU 23814 A3 CU23814 A3 CU 23814A3 CU 20080114 A CU20080114 A CU 20080114A CU 20080114 A CU20080114 A CU 20080114A CU 23814 A3 CU23814 A3 CU 23814A3
- Authority
- CU
- Cuba
- Prior art keywords
- butilftalida
- application
- same
- emulsion
- intravenous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta invención presenta una emulsión intravenosa de butilftalida que se administra mediante infusión o inyección por vía intravenosa, la cual contiene butilftalida o derivados de ella como ingrediente activo en una cantidad de 0,01- 50 wt% y un excipiente en una cantidad de 50-90wt%, basados en el peso total de la emulsión.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101023552A CN100367951C (zh) | 2005-12-16 | 2005-12-16 | 丁苯酞静脉乳剂及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20080114A7 CU20080114A7 (es) | 2010-08-30 |
CU23814A3 true CU23814A3 (es) | 2012-06-21 |
Family
ID=36934680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20080114A CU23814A3 (es) | 2005-12-16 | 2008-06-17 | Emulsión intravenosa de butilftalida y aplicación de la misma |
Country Status (13)
Country | Link |
---|---|
US (2) | US20090281177A1 (es) |
EP (1) | EP1970050B1 (es) |
JP (2) | JP5571311B2 (es) |
KR (1) | KR101061268B1 (es) |
CN (1) | CN100367951C (es) |
AU (1) | AU2006324219B2 (es) |
BR (1) | BRPI0619915B1 (es) |
CA (1) | CA2633170C (es) |
CU (1) | CU23814A3 (es) |
EA (1) | EA014518B1 (es) |
IL (1) | IL192169A (es) |
UA (1) | UA89315C2 (es) |
WO (1) | WO2007068212A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012003263A2 (pt) * | 2009-08-14 | 2015-09-22 | Opko Health Inc | formulações intravenosas de antagonistas de neuroquinina-1 |
CN102178643B (zh) * | 2011-04-29 | 2014-05-14 | 石药集团恩必普药业有限公司 | 一种丁苯酞或其衍生物的微乳透皮凝胶剂及其制备方法 |
CN107648222A (zh) * | 2012-06-06 | 2018-02-02 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞药物活性组合物及其制备方法 |
CN103505409B (zh) * | 2012-06-27 | 2017-12-26 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞注射液及其制备方法 |
CN103505414B (zh) * | 2012-06-28 | 2017-08-08 | 石药集团恩必普药业有限公司 | 丁苯酞滴鼻剂及其制备方法 |
KR102238292B1 (ko) * | 2013-02-06 | 2021-04-09 | 징준 후앙 | 경구 및 비경구적 전달을 위한 클로피도그렐 유리 염기의 안정한 약학 조성물 |
TWI547280B (zh) * | 2014-04-24 | 2016-09-01 | 長弘生物科技股份有限公司 | 穩定醫藥組合物 |
CN105030760B (zh) | 2014-04-24 | 2018-10-02 | 长弘生物科技股份有限公司 | 稳定医药组合物 |
US10610496B2 (en) * | 2015-08-28 | 2020-04-07 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
CN105796486A (zh) * | 2016-03-17 | 2016-07-27 | 南京天翔医药科技有限公司 | 丁苯酞脂肪乳注射剂及其制备工艺 |
CN110101658B (zh) * | 2018-02-01 | 2021-09-07 | 北京睿悦生物医药科技有限公司 | 丁苯酞脂微球注射液及其制备方法 |
CN110548004B (zh) * | 2018-05-30 | 2023-05-16 | 成都施贝康生物医药科技有限公司 | 一种稳定的丁苯酞大容量注射液及其制备方法 |
CN111407725B (zh) * | 2020-04-13 | 2024-07-19 | 中山大学 | 一种拉莫三嗪乳剂及其制备方法 |
CN114073694B (zh) * | 2020-08-14 | 2024-03-12 | 北京科莱博医药开发有限责任公司 | 丁苯酞制剂及其制备方法 |
CN115177614A (zh) * | 2021-04-01 | 2022-10-14 | 长春藤生物科技股份有限公司 | 正丁基苯酞的应用 |
CN114010595A (zh) * | 2021-10-14 | 2022-02-08 | 山东诚创蓝海医药科技有限公司 | 一种丁苯酞乳剂及其制备方法 |
CN114886848B (zh) * | 2022-05-20 | 2024-03-08 | 山东泰合医药科技有限公司 | 一种纳米胶束组合物制备方法及制备的纳米胶束组合物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
US4950567A (en) | 1988-01-15 | 1990-08-21 | E. I. Du Pont De Nemours And Company | Holographic optical combiners for head-up displays |
JPH01226807A (ja) * | 1988-03-04 | 1989-09-11 | Tsumura & Co | 脂肪乳剤およびその製造方法 |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
DE4015108A1 (de) * | 1990-05-11 | 1991-11-14 | Leopold Pharma Gmbh | Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe |
CN1029293C (zh) * | 1993-01-01 | 1995-07-12 | 浙江省中医院 | 薏苡仁中性油脂乳剂 |
CN1048158C (zh) * | 1993-09-09 | 2000-01-12 | 中国医学科学院药物研究所 | 芹菜甲素在制备预防和治疗哺乳动物或人类脑缺血引起的疾病的药中的应用 |
JP2000128786A (ja) * | 1998-10-28 | 2000-05-09 | Kobayashi Seiyaku Kogyo Kk | ミコナゾール含有水性注射剤およびその製造方法 |
CN1086942C (zh) | 1998-12-18 | 2002-07-03 | 中国医学科学院药物研究所 | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 |
JP2003277281A (ja) * | 2002-03-20 | 2003-10-02 | Kumamoto Technology & Industry Foundation | 静脈炎の予防及び治療のための医薬 |
CN1375288A (zh) * | 2002-05-13 | 2002-10-23 | 周桂荣 | 一种治疗脑血管疾病的药物组合物 |
ES2355133T3 (es) | 2002-08-21 | 2011-03-23 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Complejos de inclusión de butilftalida con derivados de ciclodextrina y procedimientos para su preparación. |
CN1565441B (zh) | 2003-06-20 | 2010-05-26 | 中国医学科学院药物研究所 | 左旋正丁基苯酞在制备预防或治疗痴呆的药物中的用途 |
US7115230B2 (en) * | 2003-06-26 | 2006-10-03 | Intel Corporation | Hydrodynamic focusing devices |
US20050049209A1 (en) * | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
CN1254245C (zh) * | 2003-08-26 | 2006-05-03 | 曹永强 | 羟喜树碱乳剂及其制备方法 |
CN1605336A (zh) * | 2003-10-10 | 2005-04-13 | 中国医学科学院药物研究所 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
CN1647796A (zh) | 2004-01-20 | 2005-08-03 | 中奇制药技术(石家庄)有限公司 | 左旋丁苯酞在制备预防和治疗脑缺血疾病药物中的应用 |
EP1757286B1 (en) * | 2004-06-18 | 2017-09-06 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | The application of l-n-butylphthalide in preventing and treating alzheimer's disease |
CN100361656C (zh) * | 2004-08-27 | 2008-01-16 | 石药集团中奇制药技术(石家庄)有限公司 | 丁苯酞自乳化释药体系及其制备方法和应用 |
CN1290491C (zh) * | 2004-09-20 | 2006-12-20 | 周桂荣 | 一种治疗急性缺血性脑卒中的药剂及其制备方法 |
-
2005
- 2005-12-16 CN CNB2005101023552A patent/CN100367951C/zh active Active
-
2006
- 2006-12-15 WO PCT/CN2006/003434 patent/WO2007068212A1/zh active Application Filing
- 2006-12-15 US US12/086,665 patent/US20090281177A1/en not_active Abandoned
- 2006-12-15 EA EA200870060A patent/EA014518B1/ru not_active IP Right Cessation
- 2006-12-15 AU AU2006324219A patent/AU2006324219B2/en not_active Ceased
- 2006-12-15 BR BRPI0619915-1A patent/BRPI0619915B1/pt active IP Right Grant
- 2006-12-15 KR KR1020087016969A patent/KR101061268B1/ko active IP Right Grant
- 2006-12-15 CA CA2633170A patent/CA2633170C/en not_active Expired - Fee Related
- 2006-12-15 EP EP06828348.0A patent/EP1970050B1/en active Active
- 2006-12-15 JP JP2008544744A patent/JP5571311B2/ja active Active
- 2006-12-15 UA UAA200808969A patent/UA89315C2/ru unknown
-
2008
- 2008-06-15 IL IL192169A patent/IL192169A/en not_active IP Right Cessation
- 2008-06-17 CU CU20080114A patent/CU23814A3/es not_active IP Right Cessation
-
2011
- 2011-05-20 US US13/112,180 patent/US10463614B2/en active Active
-
2012
- 2012-07-12 JP JP2012156784A patent/JP2012193206A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1970050B1 (en) | 2016-05-11 |
JP5571311B2 (ja) | 2014-08-13 |
CU20080114A7 (es) | 2010-08-30 |
CN1823729A (zh) | 2006-08-30 |
US20110288167A1 (en) | 2011-11-24 |
EP1970050A1 (en) | 2008-09-17 |
KR20080091141A (ko) | 2008-10-09 |
BRPI0619915B1 (pt) | 2021-06-01 |
CA2633170A1 (en) | 2007-06-21 |
IL192169A (en) | 2016-02-29 |
BRPI0619915A2 (pt) | 2011-10-25 |
UA89315C2 (en) | 2010-01-11 |
EA014518B1 (ru) | 2010-12-30 |
EA200870060A1 (ru) | 2009-02-27 |
IL192169A0 (en) | 2008-12-29 |
CA2633170C (en) | 2011-05-24 |
CN100367951C (zh) | 2008-02-13 |
AU2006324219A1 (en) | 2007-06-21 |
US10463614B2 (en) | 2019-11-05 |
AU2006324219B2 (en) | 2010-03-04 |
WO2007068212A1 (fr) | 2007-06-21 |
EP1970050A4 (en) | 2009-12-09 |
JP2012193206A (ja) | 2012-10-11 |
KR101061268B1 (ko) | 2011-08-31 |
US20090281177A1 (en) | 2009-11-12 |
JP2009519253A (ja) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23814A3 (es) | Emulsión intravenosa de butilftalida y aplicación de la misma | |
ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
CY1116688T1 (el) | Τροποποιητες φαρμακοκινητικων ιδιοτητων θεραπευτικων ειδων | |
BR112015023391A2 (pt) | formulações compreendendo conjugado droga-anticorpo anti-egfr | |
AR070025A1 (es) | Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica | |
AR056751A1 (es) | Composiciones pesticidamente activas que tienen actividad mejorada | |
UY30431A1 (es) | Suspensiones acuosas de tmc278 | |
AR054064A1 (es) | Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas | |
UY37789A (es) | Nuevos derivados de azaquinolina | |
CY1114703T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα (1s)-1,5-ανυδρο-1-[5-(4-αιθοξυβενζυλ)-2-μεθοξυ-4-μεθυλφαινυλ]-1-θειο-d-γλυκιτολη και μετφορμινη και χρησεις αυτης στη θεραπεια διαβητη | |
ECSP13012411A (es) | Composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona | |
CU20100032A7 (es) | Depsipéptidos cíclicos | |
AR057148A1 (es) | Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
CR20110190A (es) | Agente rodenticida sinérgico | |
CL2009000904A1 (es) | Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende. | |
EA201070448A1 (ru) | Новые композиции на основе таксоидов | |
ECSP10010683A (es) | Una formulacion farmacéutica sólida | |
CL2009001089A1 (es) | Compuestos derivados de indolo[2,1-a][2]benzacepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
ECSP11010856A (es) | Composición farmacéutica sólida | |
ECSP099080A (es) | Combinaciones farmacológicas para el tratamiento de enfermedades de las vías aéreas | |
AR079657A1 (es) | Formulacion de liberacion sostenida | |
GT201600072A (es) | Formas de dosificación farmacéutica que comprenden 1-[6-(morfolin-4-il)pirimidin-4-il]-4(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato de sodio | |
ECSP088897A (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización | |
CO2017002309A1 (es) | Composiciones farmacéuticas útiles en el tratamiento de la insuficiencia cardiaca congestiva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent | ||
FD | Lapse (for not paying fees) |